Khokon Miah Akanda/LinkedIn

Jan 14, 2026, 11:38

Khokon Miah Akanda Shares A major 4-Guideline Comparison on BP Management in Stroke

Khokon Miah Akanda, Senior Brand Executive at Apex Pharma Limited, shared on LinkedIn:

”BP Management in Stroke Care: A major 4-Guideline Comparison
(Published on “Hypertension Research” on 09 Jan 2026)

Managing Blood Pressure (BP) in acute stroke is a balancing act.

To see how the experts handle it, I have conducted a comparative analysis of these four major guidelines:

Why do these numbers matter?

As shown in the attached table, the targets change drastically based on the type of stroke:

Ischemic Stroke (The Blockage):
We often allow higher BP. The brain needs extra pressure to push blood past the clot to keep tissue alive.

Hemorrhagic Stroke (The Bleed):
We must lower BP. High pressure acts like a pump, worsening the bleeding.

Thrombolysis Patients:
If we use “clot-busting” drugs, strict BP control is needed to prevent the blockage from turning into a bleed.

This table highlights the consensus (and the differences) between these major organizations.

A useful reference for making quick, evidence-based decisions.”

Khokon Miah Akanda Shares A major 4-Guideline Comparison on BP Management in Stroke

Stay updated with Hemostasis Today.

AHA ASA ESO Health Hematology Hemostasis Hemostasis News Hemostasis Today hypertension ISH Khokon Miah Akanda Medicine stroke thrombosis WSO

'

'

'

'

'

Hemostasis Today